Fuzionaire Theranostics Company Profile, Contacts & Intelligence

Fuzionaire Theranostics Overview

Fuzionaire Theranostics is a radiopharmaceutical company on a mission to make better and more accessible theranostic treatments for people with cancer. With origins in Nobel laureate Robert Grubbs' lab at Caltech, the company's patented HetSiFA® platform enables rapid development of radioligand therapies and companion PET diagnostics, and offers manufacturing advantages in a clinical setting. The company’s pipeline addresses pressing clinical needs for several types of cancer, beginning with cancers in which gastrin-releasing peptide receptor (GRPR) is expressed, including metastatic prostate cancer.

Headquarters

2002 Timberloch Pl

Website

fuzionairetx.com

Industry

Pharmaceutical Manufacturing

Founded

2018

NAICS

Pharmaceutical and Medicine Manufacturing, Medicinal and Botanical Manufacturing

Fuzionaire Theranostics Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

Fuzionaire Theranostics People & Org Chart Preview

Sample people records show job titles and whether email or phone data is available without exposing raw contact details.

Fuzionaire Theranostics Workforce Composition

Seniority breakdown across 4 visible profiles.

Compare Similar Companies to Fuzionaire Theranostics

Explore companies in related markets and compare their industry and employee estimates.